louisiana semaglutide ileus legal team LSU Law team wins Louisiana Battle of the Law Schools Mock Popular GLP-1 drugs may lead – louisiana semaglutide gastric intestinal obstruction

While GLP-1RAs effectively improve glycemic control and cause weight loss, potential safety concerns have arisen over the years

While facilities making compounded medications are strictly regulated for certain quality practices, the compounded medications themselves are not approved or evaluated by the FDA for safety, effectiveness, or quality

Wegovy is licensed for chronic weight management

Semaglutide: frug usage statistics, United States, 20132020

BCBS of Michigan made headlines by removing all GLP-1 weight loss medications including Zepbound, Wegovy, and Saxenda from fully insured large group commercial plans effective January 2025